The Senate Committee on Health, Education, Labor, and Pensions held a hearing called the “Perspectives on the 340B Drug Pricing Program.” This hearing featured testimony from policy and industry experts who offered perspectives on what modifications are needed to fix the 340B program so that it achieves Congress’ intended goals and benefits the patients who need it most.